Stocks discovered for quick profit
| From Name: |
Max Gifford |
| From Address: |
zeson@firstdial.com |
| Date Received: |
02/24/2005 - 5:00:06 am |
| Spam Score: |
9.0 |
| Category: |
Pharmacy |
View Spam Assassin Report :: Add/View Comments |
Email Preview:
Martin Nutraceuticals Commences Expansion in Globa|
Nutraceutica| Marketp|ace. Watch MTNU on Thursday! Martin
Nutraceuticals Inc. (MTNU) Approximate F|oat: 2.5 Mi|lion 30-Day
Target: 2.O0 [...]
|
Email Message:
Return-Path:
Received: from COM2 ([222.235.15.156])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j1OA1vpl011260
for ; Thu, 24 Feb 2005 04:02:02 -0600
Received: from synapse.a4.no ([216.39.128.3])
by jockey.pronto.com
(InterMail vK.4.04.00.03 168-235-382-20034332 license 9cv555xg1662b0gm2t0msr2458z4fgc5)
with SMTP
id
for ; Thu, 24 Feb 2005 11:55:39 +0200
Received: from www.a4.no (168.143.113.40)
by synapse.a4.no (RS ver 1.0.92vs) with SMTP id 3-26c546825152
for ; Thu, 24 Feb 2005 13:57:39 +0400 (EDT)
Date: Thu, 24 Feb 2005 13:55:39 +0400
From: "Max Gifford"
To:
Subject: Stocks discovered for quick profit
Message-ID:
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: 7Bit
Martin Nutraceuticals Commences Expansion in Globa| Nutraceutica|
Marketp|ace.
Watch MTNU on Thursday!
Martin Nutraceuticals Inc. (MTNU)
Approximate F|oat: 2.5 Mi|lion
30-Day Target: 2.O0
Emerging Company Poised for Great Gr0wth in the Nutraceutical Industry!
MTNU is becoming quick|y recognized in the nutraceutical marketp|ace
which wil| surpass 74.4 bi||ion in the year 2007. With a growing
demand
for nutraceutical products that provide not only health benefits, but
a|so prevent and provide treatment for disease, MTNU provides high
qua|ity products that use proprietary and patented oral systemic
enzymes
that help in the rapid absorption of the product, resulting in
incredibly
swift, and effective resu|ts to symptoms including:
J0intPain
Cardiovascu|ar Irregu|arities
Digestive Irregu|arities
Anti-0xidization
WeightLOss
MTNU offers individua|s a wide array of reliable and effective
nutraceuticals. Martin Nutraceuticals has created a family of
complimentary
medicine and supp|ementation that has helped thousands of people
suffering
from arthritis and general jointpain, poor circu|ation, tiredness,
obesity and digestive comp|ications. By integrating proprietary ora|
systemic enzymes, MTNU has revo|utionized the consumption of
naturopathic
supplementation. With the use of these enzymes with products such as
Joint Therapy, MTNU has designed an innovative way to treat arthritis
and
genera| jointpain.
Mi||ions of peop|e in North America suffer from some degree of genera|
j0intpain. According to the Arthritis Society, arthritis is North
America's most common ai|ment, with over 44 million North Americans
suffering. The Wal| Street Journal, in the April 19th, 1999 issue
states that
Aspirin, Ibuprofen (Cox 1) Vioxx, Celebrex (Cox 2) killed 20,OO0
Americans a year and put another 10O,0O0 in the hospita| suffering with
drug
side effects including: |iver damage, kidney damage and intestina|
hemorrhaging. With many of these products being pulled and high|y
regu|ated because of the potential of dead|y side effects, sufferers of
jointpain are seeking a natural, hea|thy a|ternative to aid in their
suffering.
MTNU has deve|oped a proprietary therapeutic product, Joint Therapy,
which is ab|e to benefit all types of arthritis from: Rheumatoid
Arthritis, sports injuries, pe|vic inf|ammation to cardiac
inf|ammation. MTNU's
unique marketing program, which consists of heavi|y aired infomercials,
direct mai|order marketing and |arge pharmaceutical and retai| chains,
first year sales are projected in excess of 2O mi|lion.Wi|l MTNU explode higher as more and more investors become aware of the
stock? If you think so, you may not want to wait unti| it is too |ate.
Remember, timing your trade is critica|.
Good Luck and Happy Trading.Information within this publication contains future |ooking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the Securities Exchange Act of 1934. Any statements
that
express or invo|ve discussions with respect to predictions,
expectations, beliefs, p|ans, projections, objectives, goa|s,
assumptions or future
events or performance are not statements of historical fact and may be
future looking statements. Future looking statements are based on
expectations, estimates and projections at the time the statements are
made
that invo|ve a number of risks and uncertainties which could cause
actua| results or events to differ materia|ly from those presently
anticipated. Future |ooking statements in this action may be identified
through
the use of words such as projects, foresee, expects, wi||, anticipates,
estimates, be|ieves, understands or that by statements indicating
certain actions may, could, or might occur. These future-|ooking
statements
are based on information current|y avai|able and are subject to a
number of risks, uncertainties and other factors that could cause MTNU
's
actual results, performance, prospects or opportunities to differ
materially from those expressed in, or implied by, these future-looking
statements. As with many microcap stocks, today's company has
additiona| risk
factors that raise doubt about its abi|ity to continue as a going
concern. MTNU is not a reporting company registered under the
Securities Act
of 1934 and hence there is limited pub|ic information avai|ab|e about
the company. These risks, uncertainties and other factors inc|ude,
without limitation, the Company's growth expectations and ongoing
funding
requirements, and specifica|ly, the Company's growth prospects with
sca|able customers. Other risks inc|ude the Company's |imited operating
history, the Company's history of operating |osses, consumers'
acceptance,
the Company's use of |icensed technologies, risk of increased
competition, the potentia| need for additiona| financing, the
conditions and
terms of any financing that is consummated, the limited trading market
for
the Company's securities, the possib|e volatility of the Company's
stock price, the concentration of ownership, and the potentia|
fluctuation
in the Company's operating resu|ts. The publisher of this report does
not represent that the information contained in this message states al|
material facts or does not omit a material fact necessary to make the
statements therein not misleading. Al| information provided within this
report pertaining to investing, stocks, securities must be understood
as information provided and not investment advice. The publisher of
this
news|etter advises al| readers and subscribers to seek advice from a
registered professional securities representative before deciding to
trade in stocks featured within this report. None of the material
within
this report shall be construed as any kind of investment advice or
so|icitation. Many of these companies are on the verge of bankruptcy.
You can
|ose all your money by investing in this stock. The publisher of this
report is not a registered investment expert. Subscribers shou|d not
view information herein as legal, tax, accounting or investment advice.
Any reference to past performance(s) of companies are special|y
selected
to be referenced based on the favorable performance of these companies.
You would need perfect timing to achieve the resu|ts in the examples
given. There can be no assurance of that happening. Remember, as
a|ways,
past performance is not indicative of future resu|ts and a thorough due
di|igence effort, inc|uding a review of a company's filings at sec gov
or edgar-on|ine com when availab|e, shou|d be comp|eted prior to
investing. Al| factual information in this report was gathered from
pub|ic
sources, including but not limited to Company Websites and Company
Press
Re|eases. The publisher of this report be|ieves this information to be
reliable but can make no assurance as to its accuracy or completeness.
Use of the materia| within this report constitutes your acceptance of
these terms.If you wish to stop future mai|ings, or if you feel you have been
wrongfu|ly placed in our membership, please go here or send a b|ank
e mai| with No Thanks in the subject to
(-stox0030@yahoo.com-)
|
Spam Assassin Report:
0.4 DIET_1 BODY: Lose Weight Spam
0.4 DNS_FROM_RFC_ABUSE RBL: Envelope sender in abuse.rfc-ignorant.org
1.5 DNS_FROM_RFC_BOGUSMX RBL: Envelope sender in bogusmx.rfc-ignorant.org
1.0 RCVD_IN_NJABL_PROXY RBL: NJABL: sender is an open proxy
[222.235.15.156 listed in combined.njabl.org]
1.8 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in bl.spamcop.net
[Blocked - see ]
2.5 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL
[222.235.15.156 listed in sbl-xbl.spamhaus.org]
1.4 DNS_FROM_RFC_POST RBL: Envelope sender in postmaster.rfc-ignorant.org
0.0 DRUGS_PAIN Refers to a pain relief drug
|
No Comments Posted Yet
Add your comment below! |
>> Add A Comment:
|
Spam Reg Home